February 14th 2025
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Postpartum etonogestrel-releasing implants and depression
June 24th 2020Rates of depression at 6 weeks postpartum among adolescents and young adults (AYA) were significantly lower in those initiating immediate postpartum etonogestrel (ENG) implants compared to other birth control methods, according to new research.
Read More
Study finds plasma oxytocin levels higher in OC users
June 10th 2020Plasma oxytocin levels are significantly higher in oral contraceptive (OC) users than in to non-users, according to a study in Scientific Reports. The cross-sectional study of nearly 200 women also found that scores for satisfaction with life were higher among OC users.
Read More
Attitudes about contraception in postpartum women with pregestational diabetes
February 11th 2020Women with pregestational diabetes mellitus (DM) who recognize benefits in contraception and preconception care are much more likely to use contraception postpartum, according to a survey in the Journal of Obstetrics, Gynecologic & Neonatal Nursing.
Read More
Effectiveness of contraceptive counseling strategies
January 8th 2020Counseling strategies that target women initiating a contraception method, including structured counseling on side effects, tend to increase contraceptive continuation, according to research from BMJ Sexual & Reproductive Health.
Read More
Follow-up care and continuation rates for long-acting reversible contraceptives
November 7th 2019Continuation rates for long-acting reversible contraceptives (LARC) were high in a group of adolescent and young adult (AYA) women, according to a retrospective chart review in the Journal of Pediatric and Adolescent Gynecology.
Read More
Oral contraceptives and concurrent depressive symptoms
November 7th 2019A JAMA Psychiatry prospective cohort study found that scores for depression were higher among younger adolescents who used oral contraceptives (OCs) than those who did not, but the connection did not remain when all included age groups of the study were combined.
Read More
Progestin-only contraceptives and sexual function among first-time users
October 24th 2019A recent presentation at the 2019 American Society for Reproductive Medicine Scientific Congress & Expo compared female sexual function (FSF) in three progestin-only contraceptives (POCs) among first-time users.
Read More